Sol Gel Technologies Ltd
F:4SG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sol Gel Technologies Ltd
F:4SG
|
IL |
|
S
|
Shandong Yisheng Livestock & Poultry Breeding Co Ltd
SZSE:002458
|
CN |
|
K
|
Kinetic Development Group Ltd
HKEX:1277
|
CN |
|
N
|
Net A Go Technology Co Ltd
HKEX:1483
|
HK |
|
Bloomage Biotechnology Corp Ltd
SSE:688363
|
CN |
|
P
|
PunaMusta Media Oyj
OMXH:PUMU
|
FI |
|
M K Proteins Ltd
NSE:MKPL
|
IN |
|
Balrampur Chini Mills Ltd
NSE:BALRAMCHIN
|
IN |
|
InnoTec TSS AG
F:TSS
|
DE |
|
G
|
Gain Plus Holdings Ltd
HKEX:9900
|
HK |
|
Ampco-Pittsburgh Corp
NYSE:AP
|
US |
|
Xinyi Energy Holdings Ltd
HKEX:3868
|
CN |
|
N
|
Nexam Chemical Holding AB
STO:NEXAM
|
SE |
Balance Sheet
Balance Sheet Decomposition
Sol Gel Technologies Ltd
Sol Gel Technologies Ltd
Balance Sheet
Sol Gel Technologies Ltd
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
6
|
7
|
5
|
5
|
9
|
7
|
20
|
12
|
8
|
19
|
11
|
|
| Cash Equivalents |
6
|
7
|
5
|
5
|
9
|
7
|
20
|
12
|
8
|
19
|
11
|
|
| Short-Term Investments |
0
|
0
|
4
|
1
|
0
|
43
|
23
|
21
|
30
|
4
|
13
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
4
|
2
|
13
|
8
|
0
|
4
|
2
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
4
|
2
|
13
|
8
|
0
|
4
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
2
|
60
|
42
|
1
|
1
|
2
|
3
|
4
|
1
|
|
| Total Current Assets |
6
|
8
|
11
|
66
|
56
|
53
|
57
|
43
|
41
|
31
|
27
|
|
| PP&E Net |
1
|
1
|
2
|
3
|
4
|
4
|
3
|
2
|
2
|
2
|
1
|
|
| PP&E Gross |
1
|
1
|
2
|
3
|
4
|
4
|
3
|
2
|
2
|
2
|
1
|
|
| Accumulated Depreciation |
1
|
2
|
2
|
3
|
4
|
5
|
5
|
6
|
6
|
6
|
4
|
|
| Note Receivable |
0
|
1
|
2
|
0
|
0
|
0
|
7
|
0
|
0
|
1
|
0
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Total Assets |
8
N/A
|
11
+33%
|
15
+39%
|
70
+355%
|
61
-12%
|
59
-3%
|
69
+17%
|
47
-33%
|
45
-3%
|
36
-21%
|
30
-17%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
2
|
4
|
2
|
5
|
2
|
1
|
8
|
0
|
1
|
2
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
4
|
4
|
2
|
2
|
3
|
1
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
17
|
37
|
65
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Total Current Liabilities |
19
|
42
|
67
|
5
|
7
|
6
|
12
|
3
|
5
|
5
|
6
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
1
|
1
|
2
|
2
|
2
|
1
|
2
|
2
|
1
|
|
| Total Liabilities |
20
N/A
|
42
+114%
|
68
+61%
|
6
-92%
|
9
+53%
|
8
-6%
|
14
+64%
|
4
-68%
|
7
+50%
|
7
+5%
|
7
+2%
|
|
| Equity | ||||||||||||
| Common Stock |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
43
|
64
|
95
|
127
|
152
|
181
|
178
|
193
|
220
|
231
|
237
|
|
| Additional Paid In Capital |
31
|
32
|
42
|
191
|
204
|
232
|
233
|
235
|
258
|
259
|
259
|
|
| Total Equity |
12
N/A
|
31
-172%
|
53
-68%
|
64
N/A
|
52
-18%
|
51
-3%
|
56
+9%
|
42
-24%
|
39
-8%
|
29
-25%
|
23
-21%
|
|
| Total Liabilities & Equity |
8
N/A
|
11
+33%
|
15
+39%
|
70
+355%
|
61
-12%
|
59
-3%
|
69
+17%
|
47
-33%
|
45
-3%
|
36
-21%
|
30
-17%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
|